Meyka AI API is live for developers.Start building.
Advertisement
Nyxoah S.A.

Nyxoah S.A. (NYXH) Stock Overview

Explore Nyxoah S.A.’s financial performance, market position, analyst ratings, and future outlook.

NYXHNASDAQ
HealthcareMedical - Instruments & Supplies
$1.45
$1.43(49.65%)
U.S. Market opens in 59h 12m
Advertisement

Nyxoah S.A. (NYXH)

Meyka AI Score

Z

Key Financials

Market Cap52.3M
P/E Ratio-0.60
EPS (TTM)$-2.49
ROE-1.64%
Fundamental Analysis

AI Price Forecasts

1 Month$3.08
3 Months$0.00
1 Year Target$0.62

NYXH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nyxoah S.A. (NYXH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 20.03, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.62.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.60 and a market capitalization of 52.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-51.39%
5-Day Change
-54.25%
1-Month Change
-52.86%
3-Month Change
-62.37%
6-Month Change
-71.37%
Year-to-Date (YTD) Change
-69.57%
1-Year Change
-81.84%
3-Year Change
-83.47%
5-Year Change
-93.95%
All-Time (Max) Change
-94.17%

Contact Information

32 1 022 23 55
Rue Edouard Belin 12, Mont-Saint-Guibert, NaN, 1435

Company Facts

183 Employees
IPO DateApr 28, 2021
CountryBE
Actively Trading

Frequently Asked Questions